Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Patients With Oral Mucositis Secondary to Chemotherapy
NCT02300727Phase 2Terminated
- Start
- Feb 2015
- Primary completion
- Oct 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in oral mucositis (OM). Started Feb 2015; status: terminated.
02
Drugs
curcumin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02300727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300727.